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ABSTRACT
microRNAs (miRNAs) play key roles in cancer, but
their propensity to couple their targets as compet-
ing endogenous RNAs (ceRNAs) has only recently
emerged. Multiple models have studied ceRNA reg-
ulation, but these models did not account for the
effects of co-regulation by miRNAs with many tar-
gets. We modeled ceRNA and simulated its effects
using established parameters for miRNA/mRNA in-
teraction kinetics while accounting for co-regulation
by multiple miRNAs with many targets. Our simula-
tions suggested that co-regulation by many miRNA
species is more likely to produce physiologically rel-
evant context-independent couplings. To test this,
we studied the overlap of inferred ceRNA net-
works from four tumor contexts––our proposed pan-
cancer ceRNA interactome (PCI). PCI was com-
posed of interactions between genes that were co-
regulated by nearly three-times as many miRNAs
as other inferred ceRNA interactions. Evidence from
expression-profiling datasets suggested that PCI in-
teractions are predictive of gene expression in 12
independent tumor- and non-tumor contexts. Bio-
chemical assays confirmed ceRNA couplings for
two PCI subnetworks, including oncogenes CCND1,
HIF1A and HMGA2, and tumor suppressors PTEN,
RB1 and TP53. Our results suggest that PCI is en-
riched for context-independent interactions that are
coupled by many miRNA species and are more likely
to be context independent.
INTRODUCTION
MicroRNAs (miRNAs) are endogenous, small, noncod-
ing, single-stranded RNA molecules that are evolutionar-
ily conserved. They act as post-transcriptional regulators
that modulate the rates of both protein translation and
mRNA decay (1–3). miRNAs are involved in virtually ev-
ery cellular process, from early development (4–6) to or-
gan function (7,8). Their dysregulated expression is asso-
ciated with human diseases, including diabetes (9), cancer
(10) and infection (11). Conversely, more than half of all
human mRNAs contain likely miRNA target sites and are
post-transcriptionally regulated. Collectively, miRNAs reg-
ulate nearly all developmental pathways, including in the
context of oncogenesis (12).
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Numerous studies have shown that miRNA target abun-
dance can alter miRNA activity (13–18). The correspond-
ing regulatory mechanism has been named competing en-
dogenous RNA (ceRNA). We call miRNAs that potentially
co-regulate RNAs shared miRNAs, and note that two RNA
species may become coupled through their shared miRNAs
(19). For simplicity, we refer to shared miRNAs responsible
for inferred interactions between ceRNAs as ceRNA medi-
ators and networks of inferred ceRNA interactions as ceR-
NETs. When dysregulation of one mRNA species––e.g. via
copy number alterations (CNAs) or mutations that change
its transcriptional regulation––modulates the expression of
another mRNA through ceRNA regulation, we call the
former a ceRNA regulator and the latter a ceRNA tar-
get, respectively. Notably, however, ceRNA interactions are
mostly bidirectional, and, thus, depending on which one of
the two is independently dysregulated, either one can be
considered the regulator or the target.
Mathematical models for ceRNA regulation have been
developed by multiple groups (20,21), and include models
for ceRNA co-regulation (22), for the effects of miRNA–
target binding strength on ceRNA regulation (23,24), for
the effects of the number of miRNA binding sites per
ceRNA (25), and for the interplay between ceRNA regula-
tion and other types of regulatory interactions (26–29). Bio-
chemically validated models that focus on a specific ceRNA
interaction, mediated by a single shared miRNA, suggest
that high miRNA abundance levels and low miRNA-to-
target abundance ratios are required for physiologically rel-
evant ceRNA regulation (14,15,30). While these models
helped improve our understanding of ceRNA regulation,
they did not account for miRNAs that have hundreds of
other targets or for ceRNA regulation by multiple shared
miRNA species.
We propose a model that directly accounts for (i) reg-
ulation of hundreds of targets by each miRNA that me-
diates the interaction of a specific ceRNA-pair, (ii) exis-
tence of multiple distinct ceRNA mediators for the same
ceRNA pair and (iii) participation of each ceRNA in mul-
tiple ceRNA interactions that are mediated by distinct sets
of miRNAs. Modeling these properties addresses a key gap
in our understanding of ceRNA regulation, and suggests
that multiple ceRNA regulators can act in concert to induce
profound dysregulation of common target genes involved
in human pathophysiology. We describe the regulatory po-
tential and limitations of ceRNA regulation according to
our model and present specific conclusions drawn from its
analysis that are supported by evidence from biochemical
assays.
Simulations of ceRNA regulation using established pa-
rameter values suggested that ceRNA interactions that are
mediated by many (∼16 in our simulations) miRNA species
become virtually independent of the abundance of the indi-
vidual shared miRNAs and nearly omnipresent. Because of
the variability of the expression of their many shared miR-
NAs across contexts, we expect these interactions to be im-
plemented by a minority of the potential miRNA media-
tors in each context. To test these conclusions, we studied
the overlap between predicted ceRNETs from four highly
distinct tumor contexts. Our analysis suggested that pre-
dicted ceRNA interactions across the four contexts are me-
diated by many miRNAs––17 on average––and that these
miRNAs often have unique expression signatures in each
tumor context. Consequently, these interactions were sup-
ported by non-overlapping sets of mediating miRNAs in
each context.
MATERIALS AND METHODS
A kinetic model for of ceRNA regulation
Our steady-state formulation for RNA abundance and
miRNA–ceRNA complex formation is supported by the
observations that the half-life of most mRNAs (hours) (31),
is much longer than both the diffusion time of a regulator
(32) and the balance between miRNA–target binding and
their disassembly (33). We note that because miRNAs have
a long half-life (up to 72 h) (34–36), even relatively low rates
of miRNA synthesis can produce high abundance and con-
sistent regulation.
We first used the model to study interactions between two
arbitrary RNA species––RNA1 and RNA2––as a function
of the count and abundance of their shared miRNA regula-
tors at steady state. We then extended this model to account
for other miRNAs and other targets of the shared miRNAs
(Supplementary Figure S1). We accounted for up to hun-
dreds of additional targets for each shared miRNA species
and for up to dozens of additional miRNA regulators for
each target RNA. Our Monte Carlo analysis suggested that
the ceRNA regulation efficiency depends both on the num-
ber of shared miRNA species and on the abundance of their
high-affinity targets.
Single interaction model
We begin by describing a naı̈ve single-interaction model that
accounts for interactions between miRNAs and their tar-
get. ceRNA regulation is a consequence of changes in the
abundance of free miRNAs, which in turn is a function of
changes to miRNA degradation rates and the abundance
of miRNA–target complexes––increases in miRNA–target
complexes amount to reductions in the abundance of miR-
NAs that are free to regulate other targets. To model both,
we describe the binding of miRNAs to their targets, as well
changes to their abundance, using Michaelis–Menten kinet-






Here, m and θ represent the abundances of a miRNA
and its target, respectively, and C represents the miRNA–
target complex. The parameters kon, koff and kcat are chem-
ical rate constants with units of molecule/second. We as-
sume that miRNAs and targets that form complexes will
be degraded asymmetrically. To model this, we use the di-
mensionless rescue parameter ρ to allow for a proportion
of bound miRNAs to escape degradation and be reused
(recycled) by the RNAi machinery (23,36–38). While ρ
can take values between 0 and 1, we set ρ closer to 1
so that most bound miRNAs will escape degradation and
could be reused to target other genes; higher ρ leads to
Downloaded from https://academic.oup.com/nar/article-abstract/46/9/4354/4976480
by Universitat de Barcelona user
on 25 July 2018
4356 Nucleic Acids Research, 2018, Vol. 46, No. 9
weaker ceRNA effects. The abundance of C is dependent
on both miRNA and Ago abundances, and the latter may
have a dominant modulatory effect on miRNA activity and
target coupling (38,39). Our model produces the follow-
ing equations, which describe changes in free target abun-
dance (Equation 1), free miRNA abundance (Equation 2),
and miRNA–target complex abundance (Equation 3) as a
function of their synthesis rates (α) and degradation rates
(β)––both assumed to be constant––as well as the chemi-




= αθ − kon m · θ + koff C − βθθ (1)
dm
dt
= αm − kon m · θ + koff C + ρ kcat C − βmθ (2)
dC
dt
= kon m · θ − (koff + kcat) C (3)
Typically, the complex binds and unbinds much faster
than RNA transcription and degradation (40,41): with un-
binding expected ∼10 min after binding (42), whereas tran-
scription and degradation times have been estimated at
over 100 min for the average length mRNA (42,43). Conse-
quently, the complex is expected to be in quasi-equilibrium
with respect to the abundance of miRNAs and their tar-
gets, and the rate of change to complex abundance can be
approximated as zero, i.e. dC/dt  0. This suggests that
target-dependent miRNA degradation is the predominant
force associated with changes in free miRNA abundance at
steady state.
Setting σ as shown in Equation (4) simplifies Equations
(1)–(3) and reduces the number of system parameters, pro-
ducing Equations (5) and (6). The parameter σ can now
be interpreted as the regulatory efficiency of the miRNA–
target interaction, which depends on miRNA-binding affin-
ity.
σ = kon kcat
koff + kcat (4)
dθ
dt
= α − σ m · θ − β θ (5)
dm
dt
= αm − σ (1 − ρ) m · θ − β m (6)
The first derivative of θ (dθ/dt in Equation 5), represents
the balance between the synthesis rate α of the miRNA
target, its miRNA-mediated degradation rate σm and its
miRNA-independent degradation rate β. Similarly, the first
derivative of m (dm/dt, Equation 6) represents the bal-
ance between the miRNA’s synthesis rate αm and its degra-
dation rate, which is a linear combination of its target-
independent degradation β and its target-mediated degra-
dation (1 − ρ)σθ . This, in turn, is guided by the rescue pa-
rameter ρ (23,36,37), which depends on the quality of its
3′ pairing (18,30,36,38,44)––a common feature of miRNA
binding (45)––as well as on target abundance (16).
Model extension to multiple shared miRNAs and targets
In a physiologic setting, both shared miRNAs and their tar-
gets are embedded in a network of densely-connected inter-
acting RNAs. Each shared miRNA may have hundreds of
targets, and each target may be regulated by dozens of addi-
tional miRNAs. The kinetic model presented in Equations
(4)–(6) can be thus extended to study miRNA-mediated reg-
ulation in the presence of N competing targets and M ad-




= αθ j −
M∑
i=1






σ j iθ j−βmi mi , i=1, . . . , M
(8)
Moreover, miRNAs and their targets cooperate as a part
of a large network of interactions, with only a subset of the
genes being regulated by any given miRNA. This has the
effect of selectively depleting the miRNA pool that is avail-
able for binding and regulation.
Mean field approximation
Our model describes the kinetic dependence between RNAs
regulated by a group of miRNAs, assuming that each RNA
interacts with each miRNA. In a more realistic cellular con-
text, however, miRNAs and their targets are immersed in a
large network of interactions, and only a subset of genes are
regulated by any given miRNA. This has the effect of selec-
tively depleting the number of miRNAs that are available
for binding and regulation.
While explicitly considering all possible miRNA–target
interactions in the cell is infeasible––computational predic-
tions estimate that there might be as many of 1200 miR-
NAs regulating 14 600 target RNAs––we are not interested
in the detailed description of each interaction but on their
average effect on genes of interest, and therefore the sys-
tems can be modeled with a mean field approximation. In
our simulations, we accounted for a context-independent
regulatory network with 1220 miRNAs––of which only 15%
were expressed in each context––that targeted 14 576 genes
through 490 000 interactions (Supplementary Table S1). In-
terestingly, simulation results with up to 5× more or fewer
predicted miRNA–target interactions had almost no effect
on predicted target fold changes––average fold changes for
interactions mediated by 20 miRNAs ranged from 1.61 to
1.62 and by 10 miRNAs from 1.21 to 1.22. As a point
of reference, Cupid miRNA–target predictions are based
on a majority vote within a bootstrapping-classification
scheme; increasing the requirement from 50% to 95% of
the votes lead to less than a 0.5-fold change in the num-
ber of predicted miRNA–target interactions. Consequently,
we concluded that, under proposed parameters, the mean-
field approximation is robust to changes to the stringency
of miRNA–target prediction methods.
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We used a detailed kinetic description to model a small
subset of miRNAs and their targets and replaced all ad-
ditional interactions by the average values of miRNA and
target abundances. These were computed by averaging the










σ j i mi θ j−
Nθ∑
j=1
βθ jθ j ∼= Nθ αθ














βmi mi ∼= Nmᾱm−Nint (1−ρ) σ m̄ θ̄ −Nmβ̄mm̄=0
(9)
where Nθ , Nm and Nint are the total number of targets,
miRNAs, and miRNA-mediated interactions. The equa-
tions can be solved and the average abundances of miRNAs
and their targets, m̄ and θ̄ , can be obtained as a function of
the average transcription rates, degradation rates, and regu-
latory efficiency, ᾱθ , ᾱm, β̄θ , β̄m and σ̄ . Provided with these
average values, we can now return to the kinetic model and
include all additional interactions described by their mean
field abundances:
dθj



















where Nmj is the number of additional miRNAs that regu-
late target θj, Nθ i is the number of targets regulated by mi,
N̄m and N̄θ are respectively the average number of miRNAs
that regulate a single RNA and the average number of RNA
targets per miRNA; πa takes the value 1 if a > 0, 0 oth-
erwise. For RNA targets of interest, this factor allows us
to scale the effects of mean-field interactions as a function
of the number of miRNAs explicitly considered. Namely,
studying a particular gene and its k miRNA regulators, the
mean field approximation of miRNA effects on this target
is altered to acknowledge that the effects of k miRNAs that
regulate this target have already been accounted for.
Using this modified system of equations, we were able to
model the coupling effect between two genes with consid-
eration for some of the indirect regulation that may affect
their coupling activity. Namely, we considered the miRNAs
that target both these genes and modulate their regulation,
additional miRNAs that target one of these genes but not
the other and thus may influence the dynamic range of its
abundance, additional targets T of all said miRNA regula-
tors that may affect the abundance of free miRNAs, and the
miRNAs that target T.
Model parameters
We used the kinetic model (Equations 7 and 8) to in-
vestigate how changes to the abundance of RNA2 affect
the abundance of RNA1. We set model coefficients, in-
cluding the miRNA-independent degradation rate β, reg-
ulatory efficiency σ , RNA synthesis rates, miRNA–target
binding affinities, and the rescue parameter ρ according to
published studies, as given in Table 1 (31,33,36,46); typi-
cally, when using these parameters we obtained m > 20 and
σm > β. Published coefficients were adopted to achieve
more physiological conditions. To study relative target fold
changes, we fit generalized extreme value distributions us-
ing MathWorks Statistics Toolbox Distribution Fitting to
simulation data. Each fit is reproduced in Supplementary
Figure S5.
We used a fixed average recycling rate (ρ = 0.8) that
translate to a conservative (low) target-mediated degrada-
tion rate––equivalent to a miRNA degradation event per
five targeting events. We selected m to match a miRNA ex-
pression distribution observed in profiles of tumor samples.
Namely, we created a distribution of miRNA-basal tran-
scription rates based on miRNA expression profiles from
255 TCGA prostate cancer samples (47) and our average
mRNA synthesis rates (48). Here, for each given tumor sam-
ple, m and miRNA and mRNA abundances m and θ were
estimated using Table 1 parameters together with their ex-
pression estimates in the sample following Equation S12 in
Schwanhäusser et al. (31); the resulting m distribution was
then normalized to produce a minimum m of 0 and the av-
erage rate of 2 molecules/h (49). In our simulations, m val-
ues were sampled from the resulting distribution; we note
that profiles of TCGA cancer samples from each of four-
teen tested tumor types produced nearly identical m distri-
butions, suggesting that our m distribution is not context
specific. Using these parameters, our simulations predicted
that couplings that are mediated by twenty miRNAs lead
to a 1.5-fold change in the abundance of the target gene in
response to a 5-fold change in the abundance of the other
gene––i.e. 80% silencing––as shown in Figure 1.
Using published parameters avoids optimization and
training, and is less likely to be biased, overfitted, or lim-
ited to specialized conditions. However, because these val-
ues are only estimates and in order to better understand the
relationship between the model’s parameters, we repeated
the simulation using a wide range of parameters, includ-
ing  from 0.5 to 8 molecules/h,  from 0.005 to 0.05
(molecules/cell)−1h−1,  from 0.04 to 0.6 h–1, m from 0.005
to 0.34 h–1, and ρ from 0.7 to 0.95 (50). Note that the range
selection for  and the mean expression for m were mo-
tivated by observations made by Marzi et al. (49). We ex-
tended the range for ρ, which was previously set to 0.75 or
0.9 (38) to enable an investigation of the effects of ρ (Sup-
plementary Figures S2 and S3). The range for  and m was
chosen to span 10× around values given in Table 1 and used
for generating Figure 1 simulations.
Constructing ceRNA interaction networks (ceRNETs)
ceRNETs were assembled from independently-predicted
ceRNA interactions, with predictions made by an algo-
rithm based on the previously described Hermes and Cu-
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Table 1. Parameters used in the analytical and numerical simulations of the model to produce Figure 1, with corresponding references from the literature
Parameter Value Reference Description
α 2 molecules/h (31) Basal transcription rates
σ 0.02 (molecules/cell)−1h−1(*) (33) miRNA enzymatic regulatory efficiency
β 0.34 h−1 (half-life 2 h) (46) Degradation rate
βm 0.027 h−1 (half-life 25 h) (36)
ρ 0.8 (36) The probability that the miRNA is recycled (not degraded
with its target)
Figure 1. Simulation: the ceRNA effect as a function of the number of mediating miRNA species. We simulated changes in steady-state abundance of RNA1
as a function of the steady-state abundance of RNA2 for varying synthesis rates m of their common miRNA regulators when each of these miRNAs reg-
ulates 400 other targets. In repeated simulations, synthesis rates for each miRNA varied between 1 and 4000 molecules per hour and were selected based on
a distribution derived from TCGA miRNA expression profiles in prostate cancer tumors. All other parameters were taken from published estimates (Table
1). We report curves fitted to RNA1 fold changes (Supplementary Figure S2) in 1000 repeated simulations following RNA2 5-fold upregulation––from 50
to 250 molecules per cell––and where the two ceRNAs are co-regulated by up to 20 miRNAs. Minimal changes were observed when the two ceRNAs were
co-regulated by 1–2 miRNAs (inset), but co-regulation by 16 or more miRNAs consistently increased RNA1 abundance by ∼50%.
pid (22,51). Hermes and Cupid predict coupling between
miRNA targets based on the relative size of their shared
miRNA regulatory program and the conditional mutual in-
formation between these genes and their mediating miR-
NAs. Namely, given genes Ti and Tj, and the set of miR-
NAs that regulate them mi R(Ti ) and mi R(Tj ), their
shared program is identified by taking the intersection
mi R (Ti; Tj) = mi R (Ti ) ∩ mi R(Tj ). First, test that the size
of mi R(Ti ; Tj ) relative to the sizes of the individual pro-
grams is statistically significant at FDR < 1E–2 by Fisher’s
exact test. Then, evaluate the statistical significance pki j (P-
value) of the test CMI[mi Rk; Ti,|Tj ] > MI[mi Rk; Ti ], where
CMI and MI stand for conditional mutual information and
mutual information respectively, and the variables indicate
the expression of the corresponding RNA species (51). The
CMI is estimated using an adaptive partitioning algorithm
(52) by first iteratively partitioning the 3D expression space
evenly into 8 partitions per iteration until partitions are bal-
anced (P > 0.05 by Chi-squared test), and then summing up
CMI across partitions. P-values for each triplet are com-
puted using a null-hypothesis where the candidate modu-
lator’s expression (Tj ) is shuffled 1000 times, thus preserv-
ing the pairwise mutual information between miRNA and
target. Final significance across the entire set of miRNA
mediators is computed using Fisher’s method to integrate
both regulatory directions, i.e. Ti affecting miRk regula-
tion of Tj as well as Tj affecting miRk regulation of Ti, for




ln(pki j ) +
N∑
k = 1
ln(pkji )] was computed and
used to estimate a significance P-value for the entire pro-
gram. Note that X2 follows a Chi-square distribution, with
4N degrees of freedom, where N is the number of miRNAs
in the shared program. Finally, only prediction passing sig-
nificance of FDR < 1E–3 were selected. Note that selected
predictions by Hermes have been validated in glioblastoma
cell lines (51).
In order to identify miRNA mediators in addition to
ceRNA interactions, we modified our prediction algorithms
to perform greedy addition of miRNA mediators and to
optimize the combined P-value for each predicted interac-
tion. Namely, for each candidate interaction, we searched
for the minimum combined P-value through the greedy for-
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ward inclusion of individual miRNAs: mediators were in-
cluded only if they improved the combined P-value as esti-
mated using Fisher’s method. Those that failed to improve
the combined P-value lack functional evidence for medi-
ating regulation. We constructed interaction networks for
glioblastoma (53) (423 samples, 12 032 genes, 469 miRNAs
profiled), ovarian cancer (54) (583 samples, 12 032 genes,
713 miRNAs profiled), prostate cancer (47) (140 samples,
23 614 genes, 367 miRNAs profiled) and breast cancer (55)
(207 samples, 18 748 genes, 524 miRNAs profiled). The re-
sulting predicted networks had 527 430 (glioblastoma), 532
869 (ovarian), 476 456 (prostate) and 447 011 (breast) pre-
dicted interactions, and are given in Supplementary Tables
S2–S5.
Constructing the pan-cancer ceRNA interactome (PCI)
We studied the extent, overlap, and potential relevance
of predicted ceRNA interactions across four tumor types,
including glioblastoma (GBM) (53), ovarian (OV) (54),
prostate (PRAD) (47) and breast (BRCA) (55) adeno-
carcinoma. Cupid predicts miRNA targets by integrat-
ing sequence-based predictions made by multiple methods
(Supplementary Table S1). We note that ceRNA inference is
not based on ceRNA co-expression, and is instead based on
assessing whether the abundance of one RNA affects regu-
lation of the other by their shared miRNA program (and
vice-versa) based on the statistical significance of their con-
ditional mutual information (22,51). As such, we did not
make ceRNA inferences based on pairwise coexpression or
co-regulation but rather based on evidence for a more com-
plex, three-way interaction model; see details in Methods.
Each tumor-specific ceRNA-network included >5000
genes participating in ∼500K predicted interactions: each
was defined by two RNAs and by the miRNAs that cou-
ple them. The four networks are given in Supplementary
Tables S2–S5. Surprisingly, each pair of ceRNA networks
had ∼300 000 ceRNA interactions in common or ∼43%
on average of the total number of interactions inferred by
the algorithm in each tumor context. If the true ceRNETs
were completely tumor-context independent, and given an
estimated false-negative rate of ∼30% (56), one would ex-
pect ∼49% of the inferred ceRNA interactions to be iden-
tical across tumor pairs––each interaction will be identified
with a 70% chance in each network. Thus, this result sug-
gests that ceRNA networks are largely tumor-context in-
dependent. In comparison, other regulatory networks in-
ferred from the same data were dramatically more tumor-
specific. For instance, only 1% of transcriptional interac-
tions, as inferred by the ARACNe algorithm (57,58), were
conserved between GBM and BRCA. Similarly, compar-
isons of protein-protein interactomes, assembled by iden-
tical high-throughput experimental assays such as yeast-2-
hybrids, rarely contain >10% identical interactions (59).
Moreover, 164 623 ceRNA interactions between 3803
genes––about a third of those inferred in each tumor and
13% of the size of the union of the four ceRNETs––were
common to all four ceRNETs (FDR<1E-3); these inter-
actions form a pan-cancer ceRNA interactome (PCI) and
are reported in Supplementary Table S6. Remarkably, if
the actual ceRNETs––as opposed to our predicted net-
works that are incomplete and include false positives––were
identical in all four tumor contexts, the expected overlap
would be 24% (0.7 to the power of four, based on a 30%
false negative rate). This observation supports the hypoth-
esis that a majority of ceRNA interactions are cancer-
context independent. In addition, a comparison of the
number of miRNA co-regulators and predicted miRNA
mediators for PCI interactions in each context suggested
that, on average, PCI interactions have nearly three-times
as many co-regulating miRNAs (Figure 2C) as other
(more context-specific) ceRNA interactions. Note that co-
regulating miRNAs are miRNAs that are predicted to co-
regulate the coupled genes based on sequence analysis and
cross-species conservation––this prediction is expression-
independent––as opposed to miRNA mediators, which are
predicted based on evidence for ceRNA regulation from
RNA-expression profiles.
To test the statistical significance of the network over-
lap, we performed permutation tests by swapping one mil-
lion ceRNA interactions (network edges) at random be-
tween genes with shared miRNA regulators in each of the
four networks. Such an approach preserves node connectiv-
ity and network topology while ensuring that randomized
interactions are supported by a wild-type-comparable set
of miRNA regulators (51). Following 1E-12 such tests, we
never observed a comparable number of common interac-
tions across the four networks, suggesting an upper bound
for the P-value, P < 1E–12 (Figure 2A). The result excludes
the possibility that PCI is a by-product of network topology
or co-regulation by miRNAs. In addition, to quantitatively
address the potential contamination by transcriptional reg-
ulation events, we measured the overlap of breast and colon
cancer transcriptional networks (60) with PCI. Our analy-
sis revealed that less than 0.6% of the >185,000 candidate
interactions in each of the two contexts are represented in
PCI.
Tumor-specificity of PCI mediators
To study individual miRNAs that mediate PCI interactions
in multiple cancer types, we focused on 247 miRNAs that
could be detected in all of the four datasets. Surprisingly,
only eleven of these were inferred to mediate interactions in
all four networks (Cluster J in Supplementary Figure S7),
suggesting that pan-cancer interactions may indeed be me-
diated by different miRNA in each context. This is consis-
tent with the results of the kinetic model analysis, because
a miRNA that is in the appropriate rate-limiting kinetic
regime to mediate a PCI interaction in one context may be
expressed in a non-rate-limiting regime (i.e. too high or too
low) in a different context, thus failing to provide a signifi-
cant contribution. Furthermore, systematic analysis of PCI
interactions confirmed that miRNAs inferred to function-
ally mediate these interactions are highly context specific.
Indeed, for 66% of the PCI interactions, no miRNA was in-
ferred as mediating the interaction in all four networks. See
Supplementary Table S7 for interactions that are similarly
mediated across networks, and Supplementary methods for
detail.
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Figure 2. The overlap of ceRNETs in four tumor datasets identified a context-independent ceRNET (PCI). ceRNETs were inferred based on RNA profile
datasets from breast, glioblastoma, ovarian and prostate tumors. (A) A significantly large set of nearly 165,000 ceRNA interactions were common to
all four networks (P < 1E–12 by permutation testing) and these comprise the pan-cancer ceRNA interactome (PCI). (B) Most miRNA mediators of PCI
interactions are context specific. We used Krippendorff’s alpha coefficients () to test the overlap between mediator sets of PCI interactions across networks;
>0.8 indicates good agreement. In total, 85% of conserved interactions had −0.15 <  < 0.15 (no relation); 9% had  < −0.15 (weak dissimilarity); 6%
had  > 0.15 (weak similarity); no PCI interaction had  > 0.8. (C) Considering each context, coupled genes in PCI were co-regulated by nearly three
times more miRNAs than other ceRNET interactions, respectively.
Identifying frequent miRNA mediators in each coupling net-
work
When identifying miRNAs that were frequently predicted
mediators of target coupling in each context, we considered
only miRNAs that were predicted mediators of PCI inter-
actions. miRNAs were evaluated for the significance of the
odds ratio between the predicted frequency for that specific
miRNA and the average predicted frequency for all other
miRNA mediators across all interactions. We used a right-
tailed Chi-square (χ2) test to examine if the odds ratio in
a given context was significantly large, setting a P < 1E–5
cutoff for selection of frequent mediators. At this stringent
threshold, the analysis identified 50–100 frequent miRNAs
mediators within each context. In total, of the 247 miR-
NAs that were profiled across all four datasets, a total of
134 miRNAs were identified as frequent mediators of target
coupling (Supplementary Figure S7). Interestingly, most of
these miRNAs mediate coupling in tumor-specific fashion,
i.e. in one tumor but not in the others.
Predicting the expression of PCI targets
We used a ridge-regression with Glmnet for Matlab within
a 10-fold cross-validation analysis scheme (61,62) to predict
the expression of each PCI target from the expression of
its inferred regulators. Ridge regression was used to mini-
mize over-fitting. For each PCI target, in each 10-fold cross-
validation step, Glmnet constructs a regression model using
training samples to fit an estimate ŷ for the PCI-target ex-
pression profile y. The test-set residuals (ε̂) are then com-
piled across the 10 testing sample sets by taking the dif-
ference between the target expression profile y and the fit-
ted estimate ŷ, i.e. ε̂ = y − ŷ. To calculate R2, we take
the sum of the square of the residuals across all samples,





(yi − ȳ)2, where ȳ is the mean expres-
sion of the PCI target across the dataset. To assign P-values
to the predictive ability we used bootstrapping. Namely, in
bootstrap runs, the PCI-target expression profile y is re-
placed by y′ = ŷ + δ, where |δ| = |ε̂| and δ is populated by
random selection from (ε̂), with replacement (63,64). Glm-
net regression was repeated for one thousand bootstrapping
y′s, estimating bootstrapping R2 using 10-fold cross valida-
tion analysis to produce a null distribution and a P-value
was assigned by comparing the R2 to this distribution. Note
that this approach is virtually identical to the one used by
Barretina et al. (65), with the only difference being that the
more conservative ridge-regression was used. When com-
puting correlations between expression profiles of ceRNA
targets and the standardized totals of the expression pro-
files of their predicted PCI regulators, the expression pro-
file of each gene was quantile normalized and standardized
(51). Pearson correlations were computed between the ex-
pression profiles of the ceRNA target and the total expres-
sion of its regulators; no learning or optimization was per-
formed.
Protein activity inference
We used VIPER (66) to analyze high-throughput assays
and test whether inferred target-ceRNA protein activity
was altered following silencing of their ceRNA regulators.
VIPER estimates changes to the activity of a protein based
on changes to the expression profiles of its predicted down-
stream targets (22,67,68). Downstream targets were inferred
by ARACNe (58,69) in each tumor context.
Biochemical experiments
Details on cell and culture conditions, RNA interfer-
ence and reverse transfection, over-expression and for-
ward transfection, mutagenesis, RT-PCR analysis, high-
throughput quantitative RT-PCR analysis, and dual lu-
ciferase reporter assays are given in Supplemental methods.
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RESULTS
We first present an analysis of our simulated ceRNA in-
teractions based on a kinetic model for ceRNA regulation.
Our simulations pointed to required conditions for effec-
tive ceRNA regulation and predicted that some ceRNA in-
teractions are expected to be context independent. We then
describe our efforts to computationally and biochemically
test interactions that are predicted to be tumor-context in-
dependent.
Analysis of our ceRNA model suggests that effective regula-
tion requires many miRNA mediators
Models for ceRNA regulation suggest that effective regu-
lation is only possible when miRNA mediators operate in
a rate-limiting regime (15,25). To test this assertion, we ex-
tended an established kinetic interaction model to describe
the miRNA–target complex formation and its effects on the
abundance of both miRNAs and targets, Supplementary
Figure S1 (38,39,70). The resulting model (see Methods)
accounts for stoichiometric degradation of miRNA–target
complexes and supports the assertion that ceRNA regula-
tion is unlikely to result from purely catalytic titration of
miRNAs or from perturbations of their transcription rates
(12,27,33).
We used this model to study miRNA–target couplings
that may be mediated by multiple miRNAs (1 ≤ nm ≤
20), where each miRNA regulated over 400 other targets.
Namely, we computed the probability of observing a given
RNA1 fold-change as a function of RNA2 changes over
a 5-fold range according to our model using parameters
that were motivated by published assays and with miRNA
expression assigned based on expression distributions ob-
tained from TCGA profiles of primary tumors (47). Sim-
ulation results using Table 1 parameters are given in Fig-
ure 1. Our analysis suggested that RNA1 fold-changes be-
came virtually independent of the expression of each in-
dividual miRNA when the interaction was mediated by
many randomly selected miRNAs. The average RNA1 fold-
change was modest when the interaction was mediated by
few shared miRNAs (1 ≤ nm ≤ 10), but increasing the num-
ber of miRNA mediators (to nm > 10) led to rapid asymp-
totic convergence to a 1.5-fold change in RNA1 abundance
(under Table 1 parameters). RNA-target coupling efficiency
was highly variable and depended on individual miRNA ex-
pression when the number of miRNA mediators was 10 ≤
nm ≤ 16, but appeared independent of miRNA expression
for ceRNA interactions with nm > 16.
Varying Table 1 parameters produced qualitatively sim-
ilar results but with varying nm cutoffs and RNA1 fold
changes. Most importantly, for all parameter settings
tested, nm = 1 and nm = 6 produced negligible expecta-
tion for ceRNA effects, while nm = 16 and nm = 20 pro-
duced effects with expected physiological relevance (Sup-
plementary Figure S2); e.g. simulations with nm = 16, σ =
0.022, and ρ = 0.8, and setting σ, ρ as in Table 1, produced
fold changes ranging from 1.3 to 2.8 (Supplementary Fig-
ure S3). Every distribution in Figure 1 is given as a single
data point in Supplementary Figures S2A and S3. We also
note that 7% of genes that are potentially co-regulated by
at least one miRNA (Supplementary Table S1) are poten-
tially co-regulated by at least 16 miRNAs, and even fewer
are expected to be expressed in each context. We emphasize
that our conclusions about the number of miRNA medi-
ators that are expected for effective ceRNA regulation are
dependent on the parameters used to populate the proposed
model. Our parameter selection was motivated by estimates
from published data, but these may not be appropriate for
all contexts. However, it is important to note that, indepen-
dently of the set of parameters, our model suggests that in-
teractions with a greater number of miRNA mediators are
expected to produce greater and more consistent ceRNA ef-
fects.
Our simulations suggested that the ceRNA effect strongly
depends on the number of miRNA mediators and the sta-
bility of miRNAs––including miRNA recycling rates––as
well as their relative binding affinity. In general, as clearly
shown in Figure 1 and Supplementary Figure S2A, ceRNA
effects increased with the number of mediating miRNAs.
However, increasing the recycling rate (ρ) for interactions
that were mediated by fewer miRNAs was compensatory
and increased the ceRNA effect in our simulations (Sup-
plementary Figure S3B). In all cases, higher binding affini-
ties (σ ) and lower target-independent miRNA degradation
rates (m) lead to stronger effects (see Methods, Supple-
mentary Figure S3). In addition, our simulations suggested
that the number of targets for each miRNA mediator af-
fected their ability to mediate interactions, and that coop-
erative regulation of a target by multiple ceRNA regulators
increased the overall expected target fold change (Supple-
mentary Figure S4).
In conclusion, analyses results, together with the obser-
vation that the distribution of miRNA expression profiles is
nearly identical across tumor contexts (71,72), Supplemen-
tary Figures S2 and S3, suggested that genes that are co-
regulated by many miRNAs are more likely to be coupled
as ceRNAs, irrespective of tumor type or the abundance of
individual species of shared miRNAs. Such ceRNA inter-
actions are expected to be tumor-context independent.
PCI interactions are implemented in a context-specific man-
ner
Our model predicts that, while effective ceRNA regulation
is dependent on many factors, RNAs that are potentially co-
regulated by many shared miRNAs are more likely to result
in ceRNA interactions, independent of individual miRNA
abundance (10,73). Details on the construction of PCI are
given in Materials and Methods, but we note that PCI inter-
actions were inferred independently in each of the four tu-
mor contexts. This, however, was not the case for the specific
miRNAs that mediate them. While PCI interactions were
predicted to regulate gene expression in all context, the sets
of their mediating miRNAs were virtually non-overlapping
across contexts (Figures 2B and Supplementary Figure S3).
This observation is in line with predictions by ceRNA mod-
els: PCI interactions are generally supported by many miR-
NAs; miRNA expression distributions are similar across
contexts, but individual miRNA expression is context spe-
cific; while miRNA species that do not operate in a rate-
limiting regime are expected to have minimal contributions
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to ceRNA couplings (23,74), a sufficient number of media-
tors are expected to support PCI interactions in many con-
texts.
Our own simulations suggested that each RNA-miRNA-
RNA triplet has its own dynamics, depending on expres-
sion, degradation, and binding affinity parameters. Thus,
the contribution of each miRNA mediator to each ceRNA
interaction is dependent on many parameters and only
those mediators that are expressed within their rate-limiting
regime for this interaction will effectively contribute to
its implementation. For ceRNA pairs that share many
miRNAs––i.e. 17 miRNA species or 10 miRNA families,
on average (Supplementary Figure S6)––this all but guaran-
tees that at least some expressed miRNA species will oper-
ate in the right kinetic regime to mediate ceRNA coupling.
Indeed, each inferred PCI interaction was predicted to be
mediated by only 7 of the 17 shared miRNAs, on average
(or five miRNA families). Consequently, considering evi-
dence from tumor profiles, it is not surprising that the set of
miRNA mediators for a given coupling were tumor-context
specific (Figure 2B), and that the PCI is mostly composed
of ceRNAs that are co-regulated by many miRNA species
(Figure 2C). An example for the miRNAs predicted to me-
diate interactions in a small network clique is given in Fig-
ure 3; only 2 of the 109 miRNAs predicted to mediate these
PCI ceRNA interactions were predicted in all four contexts.
Biochemical assays support PCI’s tumor-context indepen-
dence
The PCI was inferred by analyzing independent TCGA
datasets for GBM, BRCA, OV and PRAD. We selected two
small PCI subnetworks for experimental follow-up in multi-
ple tumor contexts: one includes three oncogenes (CCND1,
HIF1A, and HMGA2) and the other includes three tumor
suppressors (PTEN, RB1 and TP53). These ceRNA inter-
actions were tested in A549 (lung cancer, LUAD), C3A
(liver cancer, LIHC), HT-29 (colon cancer, COAD), SK-
MEL-28 (melanoma, SKCA), MCF7 (BRCA), U2-OS (os-
teosarcoma, OSCA), PC3 (PRAD) and SK-OV-3 (OV) cell
lines, representing eight distinct tumor contexts, including
five that were not used for ceRNA-interaction inference;
GBM was excluded from the validation effort because the
interaction between RB1 and PTEN has been previously re-
ported in GBM cell lines (51).
In each cell line, we measured expression fold changes
of each gene, by qRT-PCR, following transfection of the
3′ UTR of each gene in its triplet, including their own 3′
UTR as a positive control; 3′ UTRs of MAPK13, RSAD1
and THNSL1 were used as negative controls. qRT-PCR as-
says were performed on Fluidigm BioMark HD system in 3
biological replicates and with three technical replicates per
biological replicate. Results are summarized in Figure 4A-
B, and detailed fold-change responses to 3′ UTR transfec-
tions are given in Supplementary Figures S8-S9; negative
controls in A549 and U2-OS are shown in Figure 4C and
Supplementary Figure S10. In total, in 80% of the exper-
iments, predicted targets were significantly upregulated (P
< 0.05 by t-test). While significant and highly consistent,
individual responses were relatively small, with an average
1.4-fold increase in gene expression and only 29 interactions
showing >50% increase; this is consistent with previously
reported results (51,56,74) and with our model’s predictions
(Figure 1, a 5-fold increase of an RNA lead to a 1.5 increase
of its ceRNA partner).
To confirm that observed interactions are mediated by
miRNA binding sites in 3′ UTRs, we tested the effects of
miRNA binding-site mutagenesis on regulation of HMGA2
by the HIF1A 3′ UTR in A549 cells (Figure 4D–F), com-
pared regulation of PTEN cDNA and 3′ UTRs in PC3 (Fig-
ure 5A), and rescued the effects of siRB1 on PTEN and
TP53 expression by transfecting RB1 3′ UTRs in U2OS
(Figure 5B and C). We selected two HIF1A 3′ UTR miRNA
binding sites for deletion. These sites, and associated miR-
NAs, had high confidence scores for regulating the two
genes and mediating their interaction by members of mul-
tiple miRNA families. Each site, corresponding to a 7-base
seed match of the regulating miRNAs, was independently
deleted to produce two 3′ UTR mutants, 1 and 2 (Fig-
ure 4D). Transfections of mutants showed weaker HMGA2
up-regulation and siHIF1A rescue when compared with
wildtype 3′ UTR (Figure 4E). 1 and 2 also showed re-
duced sensitivity to miRNAs that are predicted to target the
deleted sites (Figure 4F).
To disentangle the effects of RNA and protein-mediated
regulation, we transfected PC3, a PTEN –/– cell line, with
PTEN cDNA and PTEN 3′ UTR. PTEN 3′ UTR, but not
cDNA transfections lead to significant upregulation of RB1
and TP53 in PC3 (Figure 5A). Moreover, in U2OS, siRNA-
mediated silencing of RB1 downregulated PTEN and TP53,
while RB1 3′ UTR transfection upregulated PTEN and
TP53 expression and rescued the effects of siRB1 transfec-
tion (Figure 5B and C). These results suggest that observed
effects are independent of protein activity and dependent
on regulation by 3′ UTRs and the miRNA binding sites em-
bedded in them.
To further test the effects of perturbations targeting
ceRNA regulators on the activity of their protein targets, we
used VIPER to analyze 13 high-throughput assays where
each of the six genes was targeted by RNAi and genome-
wide expression was measured by microarrays or RNA-Seq
(75–85). To determine whether VIPER could be used to
evaluate these assays, we first tested whether silencing of
each gene resulted in a significant (P < 0.05, VIPER) dys-
regulation to its inferred activity; e.g. siPTEN was expected
to alter PTEN activity. In total, four assays failed this con-
trol and were eliminated from further consideration. Results
of 18 tests based on the remaining 9 assays are given in Sup-
plementary Figure S11. In total, 16 of the 18 tests in os-
teosarcoma, breast, lung, ovary, prostate, and colon cancer
cell lines showed significant reductions in the activity of our
tested cancer genes following silencing of their ceRNA reg-
ulators (P < 0.05). Taken together, an investigation of six
predicted ceRNA interactions from two networks of key
cancer genes suggests that these interactions are present
in every tested context, lead to changes to ceRNA–target
protein activity, and are dependent on regulator 3′ UTR
expression––and particularly on miRNA binding sites in 3′
UTR––but not on ceRNA-regulator protein expression.
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1 miR-16 N N N Y
2 miR-16-1* U U N U
3 miR-17 N N Y N
4 miR-18a N N N N
5 miR-18b Y N N Y
6 miR-19a Y Y Y Y
7 miR-20a N Y Y N
8 miR-20b N Y N N
9 miR-33a N N Y N
10 miR-34b* Y N N N
11 miR-93 Y N N N
12 miR-93* U U N U
13 miR-96 N N N Y
14 miR-106a N Y N Y
15 miR-106b Y Y N Y
16 miR-155 N Y Y Y
17 miR-195 N N N Y
18 miR-302a* N Y Y U
19 miR-302d N N N U
20 miR-340 U U Y N
21 miR-373 Y N N U
22 miR-424 N Y Y Y
23 miR-449a Y N Y U
24 miR-495 Y Y N Y
25 miR-518d-5p Y U N U
26 miR-518f* Y N N U
27 miR-519d N N N U
28 miR-520c-5p Y U U U
29 miR-520e N Y N U
30 miR-522 N N Y U
31 miR-526a Y N U U
32 miR-526b* Y N N U
33 miR-548c-3p Y N N Y
34 miR-548d-3p N Y Y U
35 miR-569 Y Y Y U
36 miR-576-3p U U N U
37 miR-656 Y Y N U
38 miR-944 U U N U
16 13 12 11




# miR mediators 
(individual)









1 let-7a Y N N N
2 let-7b N Y Y N
3 let-7c N Y N N
4 let-7d N N N Y
5 let-7f N Y N Y
6 let-7g N Y N Y
7 miR-7 N N N N
8 miR-15a Y N N Y
9 miR-15b N N N N
10 miR-16 Y N N N
11 miR-16-1* U U N U
12 miR-17 N Y Y Y
13 miR-19a* U U N U
14 miR-20a N Y N Y
15 miR-20b N N Y N
16 miR-26a N N N N
17 miR-29a* U U N N
18 miR-33a N Y N N
19 miR-33b Y N N N
20 miR-34a N N Y Y
21 miR-34b* N Y N N
22 miR-93* U U N U
23 miR-98 N N N Y
24 miR-106a N N N Y
25 miR-106b N Y N N
26 miR-142-5p N Y N N
27 miR-185 N N Y N
28 miR-195 N Y N N
29 miR-198 Y N N N
30 miR-200b* U U N N
31 miR-221* U U N N
32 miR-223* U U Y U
33 miR-224 Y N N N
34 miR-302a* N Y N U
35 miR-365 Y Y N Y
36 miR-424 N Y N Y
37 miR-452* Y N N U
38 miR-491-3p U U N Y
39 miR-497 N Y Y N
40 miR-522 N N N U
41 miR-548c-3p N N N N
42 miR-548d-3p Y N N U
43 miR-569 N Y N U
44 miR-655 N N N U
9 16 7 12
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1 let-7e N N N Y
2 let-7g* U U N U
3 miR-16 Y N Y N
4 miR-16-1* U U Y U
5 miR-17 N Y N N
6 miR-17* N Y Y N
7 miR-19b-1* U U N Y
8 miR-19b-2* U U N U
9 miR-20a N N Y N
10 miR-20b N Y N Y
11 miR-28-5p N N N Y
12 miR-31 N N Y N
13 miR-33a Y N N Y
14 miR-34b* Y N N N
15 miR-34c-5p N N N U
16 miR-92a-2* U U N U
17 miR-93* U U Y U
18 miR-106a N N N N
19 miR-106b Y Y Y Y
20 miR-107 N N N Y
21 miR-143* U U N Y
22 miR-148b N N N N
23 miR-152 N N N Y
24 miR-186 Y N N Y
25 miR-194 N N Y Y
26 miR-195 Y Y Y Y
27 miR-217 N N Y U
28 miR-298 U U Y U
29 miR-302a* Y N N U
30 miR-335* U U N N
31 miR-338-3p N Y Y Y
32 miR-361-5p Y Y N Y
33 miR-376a N N N Y
34 miR-376b N N N N
35 miR-376c N N Y N
36 miR-380 N N Y U
37 miR-421 N N N N
38 miR-424 Y N N Y
39 miR-433 N N N U
40 miR-493* Y Y N U
41 miR-494 N N N Y
42 miR-509-3-5p U U Y U
43 miR-509-5p U U Y U
44 miR-519a Y N N U
45 miR-519b-3p N N N U
46 miR-519c-3p N N N U
47 miR-520d-5p N N N U
48 miR-520g Y N N U
49 miR-520h Y N N U
50 miR-522 Y N N U
51 miR-524-5p N N N U
52 miR-539 N Y N Y
53 miR-548c-3p Y N Y N
54 miR-548d-3p Y N N U
55 miR-556-5p Y N Y U
56 miR-569 Y N Y U
57 miR-589* N N N U
58 miR-590-3p U U N U
59 miR-802 N N Y U
60 miR-888 U U N U
61 miR-889 N U Y U
18 9 21 18
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Color Key:
Figure 3. A densely connected subnetwork of oncogenes in PCI is mediated by varying populations of miRNAs across the four ceRNETs. CCND1,
HMGA2 and HIF1a are predicted to regulate each other as ceRNAs in PCI. As an illustrating example of context-dependent mediation for PCI interac-
tions, we identified the miRNAs that are predicted to mediate each of the three interactions in each of the four ceRNETs. For example, Cupid predicted
that CCND1 and HIF1a have 38 shared miRNAs, but their ceRNA interaction was predicted to be mediated by only 16, 13, 12 and 11 miRNAs in
BRCA, GBM, OV, and PRAD, respectively. miR-19a was the only mediator predicted to mediate this interaction in all four ceRNETs, resulting in no
cross-ceRNET similarity: Krippendorff’s alpha coefficient of −0.03 and Jaccard index of 0.03.
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pmiR Luc vectors with HIF1A 3’ UTR
5'    UAUGCACUUUGUCGC   3'
5'    ACAUUGUACAAAUUU   3'
R-LUC































































































































































miRNAs predicted to target ᴪ1 miRNAs predicted to target ᴪ2
3’ UTR transfections upregulate ceRNA-target expression in two cancer-gene networks
in cell lines from multiple tumor contexts
Mutated H1F1A 3’ UTRs are less responsive to miRNA transfection 
Figure 4. Validation of oncogene and tumor-suppressor PCI subnetworks. Significant mRNA upregulation in response to 3′ UTR transfection of candidate
PCI regulators in eight cell lines is shown for (A) a three-oncogene subnetwork and for (B) a three-tumor-suppressor subnetwork, and (C) negative controls.
For each transfected 3′ UTR and each target gene, the panels identify cell lines where ceRNA targets were significantly (P < 0.05) upregulated in response
to transfection (filled dots); missing dots designate cell lines where target expression was too low to be measured. Fold changes are depicted by a green-to-
red log-scale gradient, with red showing a 2-fold change; fold change values are given in Supplementary Figures S8-S10. (D) Deletions of 7-base predicted
miRNA binding sites were used to generate HIF1A 3′ UTR (WT) mutants (1 and 2); deletions at 1 and 2 start at positions 3844 and 3964 of
NM 001530, respectively. (E) Transfections of constructs containing 1 and 2 had weaker HMGA2 upregulation and rescue by HIF1A silencing,
compared to WT constructs. Negative controls include perturbations of MAPK13, RSAD1 and THNSL1. (F) Luciferase activity fold changes of constructs
containing WT, 1, and 2 after transfecting miRNAs predicted to modulate HMGA2 regulation and target deleted sites. The region deleted in 1 was
predicted to bind miR-17-5p, miR-18a-5p, miR-20a-5p and miR-106a-5p; 2 lost a predicted binding site for let-7g-3p, miR-493-5p and let-7a-2-3p; miR-
301a-3p was predicted to target WT, 1 and 2; and miR-557 was not predicted to regulate HIF1A. Notations ** and *** denote P < 0.01 and P < 0.001,
respectively. Data are represented as mean ± SEM.
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Regulation by tumor suppressor 3’ UTR but not cDNA
A


































































































































































































































































































































































Figure 5. Validation of tumor-suppressor PCI interactions. (A) Perturbations using PTEN 3′ UTR and cDNA in PC3, where PTEN is –/–, suggest that
RB1 and TP53 regulation by the PTEN 3′ UTR is independent of PTEN protein expression. (B) Silencing RB1 and transfecting its 3′ UTR in U2-OS cells
down and upregulated PTEN and TP53 mRNA expression, respectively. Transfecting RB1 3′ UTR rescued the effects of siRB1 on PTEN and TP53 mRNA
expression (P < 0.1 for PTEN and P < 1E–4 for TP53). Negative controls include perturbations of MAPK13, RSAD1 and THNSL1. (C) siRNA-mediated
silencing of RB1 in U2-OS, SK-MEL-28 and A549 reduced PTEN and TP53 luciferase activity. Data are represented as mean ± SEM.
PCI interactions predict expression in multiple contexts
To test whether PCI interactions may be present in contexts
not used for its construction, we used PCI to predict expres-
sion in eight additional datasets. A unique property of ceR-
NETs is an increase in correlation between the expression of
a specific target and the total expression of its ceRNA part-
ners as a function of the number of partners (51). This prop-
erty has been attributed to combinatorial regulation by mul-
tiple ceRNA regulators that compete for common miRNAs.
To evaluate the predictive power of PCI, we report on (a) an
evaluation of the predictive ability of PCI on the expression
of targets in both tumor-related and non-tumor contexts
and (b) median correlations between expression profiles of
genes and the standardized totals of the expression profiles
of their predicted PCI regulators.
We used a ridge-regression within a 10-fold cross-
validation analysis scheme to predict the expression of each
PCI target from the expression of its inferred regulators;
see Methods for details. Our results, given in Figure 6, con-
firmed that PCI interactions are predictive of ceRNA-target
expression in the contexts used for its construction––GBM,
OV, PRAD and BRCA tumor profiles––as well as in other
tumor contexts, disease contexts, and pools of expression
profiles from healthy cells from Gene Expression Atlas (86).
In every context tested, using both ridge regression and
Pearson correlation, the expression of genes with few regu-
lators in PCI could not be predicted, while profiles of genes
with many regulators could be significantly predicted using
the expression of their regulators. This observation is con-
sistent with previous results based on ceRNA networks that
were constructed in a context-specific manner (51).
DISCUSSION
Recently, multiple kinetic models for ceRNA regulation
have provided a mechanistic rationale for the coupling
of RNA species that are regulated by the same miRNAs
(15,23,25,74). However, these models do not account for
the effects of mediation by multiple miRNA species with
many other targets. We proposed a model for ceRNA regu-
lation that accounts for the effects of mediation by multiple
miRNA species with hundreds of targets and for regulation
by multiple ceRNAs. Our analyses suggested that effective
ceRNA regulation is strongly influenced by the abundance
of its miRNA mediators and by the number their targets
and that interactions that are mediated by many miRNA
species are more likely to produce measurable effects. As
observed by others, our model predicted that one miRNA
regulator is not likely to mediate physiologically relevant
ceRNA regulation (30).
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Figure 6. The predictive ability of PCI is context-independent. A unique property of ceRNETs is the increase in predictive ability and correlation between
expression profiles of targets and their regulators as a function of the number of regulators (given in the x-axis in log2 scale) (51). (A) The predictive signif-
icance of PCI interactions as a function of the number of regulators, as estimated using ridge regression analysis, assigning significance by bootstrapping
residuals. ceRNA targets with the same number of predicted regulators were binned together, and median P values are reported for each group. (B) Pear-
son correlation between the expression profiles of each target and the average expression of their regulators. Pearson correlation obtained from shuffled
networks shown using dashed lines, P-values estimated using K-S test. As shown, in every context, predictive ability improved with the number of ceRNA
regulators. For both (A) and (B), the top, middle, and bottom rows summarize analyses of TCGA datasets used to build the PCI, TCGA datasets for other
tumor types, and both cancer and non-cancer datasets from Gene Expression Atlas, respectively.
Based on our model, we hypothesized that ceRNAs
that are co-regulated by many miRNAs are expected to
be context-independent. Interestingly, an analysis of the
overlap between ceRNETs that were independently recon-
structed from four tumor contexts––the PCI––suggested
that surprisingly many ceRNA interactions were predicted
in each of the four contexts and that these interactions were
enriched for genes that are co-regulated by many miRNAs.
Further analysis showed that PCI interactions are predic-
tive of gene expression in each of twelve contexts, includ-
ing tumor- and non-tumor cells. Moreover, biochemical as-
says supported PCI’s context-independent nature. An im-
portant consequence of this work is that oncogenic drivers
that were previously thought to be completely uncoupled
present strong crosstalk, including CCND1, HIF1A and
HMGA2 and PTEN, TP53 and RB1. This suggests that
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aberrant up or downregulation of any of these genes may
produce an effect greater than what may be accounted for
in isolation. We plan to explore the full coupling of onco-
genes and tumor suppressors in a follow-up manuscript.
Our analysis suggests that ceRNA interactions that are
mediated by many miRNAs are expected to have physio-
logically relevant effects and that models for ceRNA reg-
ulation must make an effort to account for all RNAs that
influence ceRNA regulation. Unexpectedly, our model pre-
dicted that thousands of ceRNA interactions are expected
to regulate gene expression in context-independent fashion
and that these interactions form a unique regulatory net-
work that may be regulating and altering gene expression in
virtually all cellular contexts.
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